• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, November 19, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Elevated Interleukin-10 Supports Atypical B Cell Expansion in Complex Immunodeficiency

by
November 18, 2026
in Health
Reading Time: 6 mins read
0
Elevated Interleukin-10 Supports Atypical B Cell Expansion in Complex Immunodeficiency

Elevated Interleukin-10 Supports Atypical B Cell Expansion in Complex Immunodeficiency

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Medical researchers have revealed that elevated circulating levels of interleukin-10 exhibit a significant positive correlation with the expansion of atypical CD21-low B cells in patients diagnosed with common variable immunodeficiency. This investigation focused on elucidating the immunological drivers behind secondary non-infectious complications, which frequently affect individuals with this primary immunodeficiency disorder. By examining stratified patient cohorts and control groups, the team established that increased interleukin-10 is not simply an inactive marker of chronic inflammation, but functionally interacts with expanding B-cell subsets. These atypical cells, marked by low CD21 density and high intracellular expression of the transcription factor T-bet, accumulate in the bloodstream and inflamed tissues. The findings provide critical insights into the aberrant signaling pathways that sustain pathological immune dysregulation in vulnerable patients.

Common variable immunodeficiency is clinically categorized into two primary presentations: patients presenting exclusively with recurrent infections, and those who develop complex autoimmune, lymphoproliferative, or inflammatory complications. Patients with complex disease frequently exhibit profound disruptions in immune homeostasis, including marked reductions in switched memory B cells, loss of naive CD4-positive T lymphocytes, and a pronounced shift toward type-1 immunity. In parallel, these patients often display an expansion of atypical T-bet-high CD21-low B cells. First identified more than two decades ago in individuals with human immunodeficiency virus and immunodeficiency, these cells have since been recognized across numerous chronic inflammatory diseases under names such as extrafollicular or atypical B cells. They possess distinct transcriptional profiles, altered B-cell receptor signaling, and modified glycosylation relative to conventional B cells. Characterized by reduced proliferative capacity and residual antibody production, they can act as potent antigen-presenting cells within chronically inflamed microenvironments.

Interleukin-10 is a pleiotropic cytokine recognized for both regulatory and stimulatory activities in maintaining immune homeostasis. Produced by diverse cell types including monocytes, macrophages, regulatory T cells, and effector T lymphocytes, it dampens excessive inflammation by suppressing pro-inflammatory mediators such as interferon-gamma, interleukin-2, interleukin-3, and tumor necrosis factor-alpha, while preserving mucosal tissue integrity. Beyond these immunosuppressive actions, interleukin-10 also potently stimulates B-cell maturation and antibody production during T-cell-dependent immune responses. Elevated circulating interleukin-10 has been observed in chronic autoimmune conditions, such as systemic lupus erythematosus and rheumatoid arthritis, which also feature prominent expansions of atypical CD21-low B cells. Because elevated interleukin-10 occurs alongside expanded CD21-low B cells in these diverse disorders, the researchers sought to clarify the precise relationship between increased cytokine concentrations and the differentiation, survival, and cellular expansion of these atypical lymphocytes in patients with complex immunodeficiency.

The study analyzed a clinical cohort of seventy-three patients fulfilling European Society for Immunodeficiencies diagnostic criteria, comprising thirty-seven females and thirty-six males with a median age of fifty-three years. Participants were classified into infections-only or complex disease phenotypes and further categorized under the EUROclass system, distinguishing patients with elevated circulating CD21-low B cells above ten percent from those with normal frequencies. Blood samples from healthy donors served as primary physiological controls. In addition to peripheral blood analyses, the investigators evaluated secondary lymphoid tissue biopsies from immunodeficient donors and tonsillar control tissue from surgical tonsillectomy patients without immunodeficiency. Comparative tissue assessments also incorporated biological samples from two patients diagnosed with sarcoidosis and six individuals with rheumatoid arthritis. All protocols operated under approved institutional ethics guidelines following the Declaration of Helsinki, with documented informed consent from all participants, ensuring a well-controlled experimental framework.

Serum cytokine profiling and targeted proteomics characterized the circulating immune landscape in these cohorts. Using multiplex bead assays, the researchers measured serum interleukin-10, while proximity extension immunoassays evaluated one hundred and seventy-two unique immune-related proteins across forty-five individuals, including twenty-five immunodeficiency patients and ten healthy controls. The proteomic screening confirmed that serum interleukin-10 levels were markedly higher in immunodeficient patients than in healthy donors, with complex disease cases demonstrating higher concentrations than infections-only patients. Strikingly, patients with active autoimmune complications, specifically autoimmune cytopenias, exhibited significantly higher interleukin-10 levels than individuals without autoimmunity. Furthermore, interleukin-10 concentrations did not correlate with patient sex or the presence of known genetic variants in susceptibility genes such as NFKB1 and TNFRSF13B.

To identify the cellular sources contributing to elevated interleukin-10, the researchers analyzed transcriptomic and protein data from peripheral blood and affected tissues. Re-examination of single-cell RNA sequencing datasets from peripheral blood mononuclear cells showed interleukin-10 transcription across multiple lineages, including monocytes, dendritic cells, and regulatory T cells, with highest per-cell expression concentrated within exhausted CD8-positive T lymphocytes and a subset of CD21-low B cells. Bulk RNA sequencing confirmed elevated interleukin-10 transcripts in purified naive CD21-low B cells from complex disease patients compared to conventional CD21-positive B cells from patients and healthy donors. Functional ex vivo restimulation of peripheral blood mononuclear cells with phorbol 12-myristate 13-acetate and ionomycin corroborated these findings at the protein level. Flow cytometry revealed a significantly higher proportion of intracellular interleukin-10-positive cells within the naive CD21-low B-cell compartment than in healthy conventional B cells, confirming that these atypical cells contribute directly to cytokine production.

Interleukin-10 upregulation was likewise evident within inflamed tissues where atypical B cells accumulate. In bronchoalveolar lavage fluid from immunodeficient patients suffering from interstitial lung disease, interleukin-10 expression was elevated across multiple cell populations relative to sarcoidosis disease controls. In these pulmonary samples, localized CD21-low B cells and expanded CXCR5-negative, PD-1-high peripheral helper T cells exhibited high interleukin-10 transcript abundance. Flow cytometry confirmed that these lung-infiltrating helper T cells produced interleukin-10 protein while co-expressing interferon-gamma, mirroring cytokine secretion patterns observed in helper T cells isolated from rheumatoid arthritis synovial tissue. Elevated interleukin-10 concentrations were also confirmed in rheumatoid arthritis synovial fluid, matching levels detected in immunodeficiency patients with expanded atypical B cells. Transcriptomic analyses of archived cohorts further demonstrated increased interleukin-10 in CD8-positive T cells from reactive lymph nodes and duodenal biopsies from enteropathy patients, illustrating widespread cytokine presence across affected anatomical niches.

The investigators next examined whether atypical B cells maintain the molecular capacity to respond to elevated interleukin-10. Surface staining demonstrated that CD21-low B cells from patients with expanded atypical populations expressed significantly higher levels of both interleukin-10 receptor subunits, IL-10RA and IL-10RB, compared to conventional naive B cells from healthy controls or patients with normal B-cell distributions. To determine whether elevated receptor expression supported downstream signaling, isolated B cells were exposed to recombinant interleukin-10 and analyzed for STAT3 phosphorylation. Although atypical CD21-low B cells exhibited higher baseline levels of phosphorylated STAT3 prior to stimulation, their stimulation index upon cytokine exposure was equivalent to that observed in conventional B-cell subsets. This demonstrated preserved receptor sensitivity and functional signal transduction, proving that expanded CD21-low B cells remain fully capable of perceiving and processing interleukin-10 signals within their local immunological microenvironment.

In vitro activation cultures assessed how interleukin-10 influences the initial induction of atypical B cells from isolated naive precursors. Naive B cells, isolated to greater than ninety-three percent purity, were stimulated for forty-eight hours with anti-immunoglobulin M antibodies, interferon-gamma, and CD40 ligand in the presence or absence of interleukin-10. The cytokine did not impair the core induction program driven by interferon-gamma and antigen-receptor crosslinking, leaving upregulation of CD11c and CXCR3 intact. Instead, adding interleukin-10 modestly increased expression of the activation markers CD25 and CD86, significantly enhanced the homing receptor CXCR5, and induced slight decreases in CD27 and IL-10RA surface density. These results confirmed that interleukin-10 does not counteract type-1-driven phenotypic induction, but fine-tunes surface activation markers on developing cells, demonstrating that the cytokine functions compatibly alongside key pro-inflammatory polarizing signals during early B-cell activation.

In six-day differentiation assays, the team demonstrated that interleukin-10 can functionally substitute for interleukin-21 during CD40L-dependent differentiation of naive B cells, driving the generation of CXCR3-high CD21-low-like B cells and supporting plasmablast differentiation in the presence of interferon-gamma. Under Toll-like receptor stimulation with CpG, interleukin-10 and interleukin-21 supported comparable proportions of atypical B cells and antibody-secreting cells. The researchers acknowledged limitations, including cohort genetic heterogeneity, reliance on disease controls for tissue analyses, and the simplified nature of in vitro systems relative to complex tissue microenvironments. Nonetheless, these findings indicate that elevated interleukin-10 provides supportive survival and differentiation signals in chronically inflamed tissues with limiting interleukin-21, identifying a functional mechanism underlying atypical B-cell accumulation in complex immunodeficiency.

Subject of Research: The role of elevated interleukin-10 in supporting CD21-low B-cell differentiation and survival in common variable immunodeficiency.

Article Title: Elevated IL-10 is Linked With the Expansion of T-bethighCD21low B Cells in Patients With Common Variable Immunodeficiency

Article References: Cousin, V., Graumann, A., Geiger, V., Sökler, D., Bez, P., Gutenberger, S., Glaser, C., Andrieux, G., Boerries, M., Frye, B. C., Zissel, G., Calvillo, C. L., Rodriguez-Ubreva, J., Ballestar, E., Hauck, F., Voll, R. E., Chevalier, N., Keller, B., & Warnatz, K. (2026). Elevated IL-10 is Linked With the Expansion of T-bethighCD21low B Cells in Patients With Common Variable Immunodeficiency. Journal of Clinical Immunology, 46(1), Article 83. https://doi.org/10.1007/s10875-026-02058-2

Image Credits: AI Generated

DOI: 10.1007/s10875-026-02058-2

Keywords: Common Variable Immunodeficiency, Interleukin-10, CD21low B Cells, T-bet Transcription Factor, Autoimmune Cytopenia, STAT3 Phosphorylation, Interferon-gamma, Interleukin-21, Peripheral Helper T Cells, Bronchoalveolar Lavage, Rheumatoid Arthritis, Proximity Extension Immunoassay, Luminex Platform, B Cell Differentiation, EUROclass Classification, Single-Cell RNA Sequencing, Immune Dysregulation

News Source: Ophelia Keating. (November 18, 2026). Elevated Interleukin-10 Supports Atypical B Cell Expansion in Complex Immunodeficiency. Scienmag.

Tags: Autoimmune CytopeniaB cell differentiationbronchoalveolar lavageCD21low B Cellscommon variable immunodeficiencyEUROclass Classificationimmune dysregulationinterferon-gammainterleukin-10Interleukin-21Luminex PlatformPeripheral Helper T CellsProximity Extension ImmunoassayRheumatoid arthritissingle-cell RNA sequencingSTAT3 phosphorylationT-bet Transcription Factor
Share12Tweet7Share2ShareShareShare1

Related Posts

Experts Define Transdisciplinary Competency Framework for Long-Term Care Case Management

Experts Define Transdisciplinary Competency Framework for Long-Term Care Case Management

November 19, 2026
Thymic Restoration Strategy Targets Age-Related Immune System Decline

Thymic Restoration Strategy Targets Age-Related Immune System Decline

November 19, 2026

Hospitalization Rates Rise Under China Case-Based Payment Reform

November 19, 2026

Pre-Rollout Survey Finds Eighteen Percent HPV Vaccine Uptake Among Chinese College Women

November 19, 2026

POPULAR NEWS

  • Corncrake Flagship Status Does Not Guarantee Local Recognition in Rural Romania

    Corncrake Flagship Status Does Not Guarantee Local Recognition in Rural Romania

    29 shares
    Share 12 Tweet 7
  • Pre-Rollout Survey Finds Eighteen Percent HPV Vaccine Uptake Among Chinese College Women

    29 shares
    Share 12 Tweet 7
  • Military Physicians Issue Fewer Medical Exemptions as Decision Fatigue Mounts Across Workdays

    29 shares
    Share 12 Tweet 7
  • Counseling and Mobile App Increase Postpartum Modern Contraceptive Uptake in Jordan

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Experts Define Transdisciplinary Competency Framework for Long-Term Care Case Management

Thymic Restoration Strategy Targets Age-Related Immune System Decline

Hospitalization Rates Rise Under China Case-Based Payment Reform

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.